Evidence map›Paper›PMID 40390672›Full record

ReviewInternational journal of stroke : official journal of the International Stroke Society2025

Frailty and stroke: Global implications for assessment, research, and clinical care-A WSO scientific statement.

Nicholas R Evans, João Pinho, Lucy Beishon, Tu Nguyen, Aravind Ganesh, Bharathi Balasundaram, Ragnhild Munthe-Kaas, Jonathan Hewitt, Dorcas B C Gandhi, Terry J Quinn and 1 more

Abstract readReviewConsensus Statement
In one paragraph

Review in International journal of stroke : official journal of the International Stroke Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Frailty and Cardiovascular Risk.European cardiology · 2026
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nicholas R EvansDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UK.ORCID 0000-0002-7640-4701
João PinhoRWTH Aachen University, Braga, Germany.ORCID 0000-0002-3977-7146
Lucy BeishonUniversity of Leicester, Leicester, UK.
Tu NguyenThe George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
Aravind GaneshDepartments of Clinical Neurosciences and Community Health Sciences, The Hotchkiss Brain Institute, the Mathison Centre for Mental Health Research and Education, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.ORCID 0000-0001-5520-2070
Bharathi BalasundaramDepartment of Psychological Medicine, Changi General Hospital, Singapore.
Ragnhild Munthe-KaasDepartment of Medicine, Kongsberg Hospital, Vestre Viken Hospital Trust, Oslo, Norway.ORCID 0000-0002-2036-0674
Jonathan HewittCardiff University, Cardiff, UK.
Dorcas B C GandhiChristian Medical College & Hospital, Ludhiana, PB, India.ORCID 0000-0002-9616-7870
Terry J QuinnSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.ORCID 0000-0003-1401-0181
Richard I LindleyThe University of Sydney, Australia.ORCID 0000-0002-0104-5679

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty is common in stroke and has important disease- and treatment-modifying effects. The need to develop clinical practice and research for the impact of frailty on stroke is likely to increase in the coming decades as the global population ages, resulting in a higher burden of frailty that is likely to be borne disproportionately by lower- and middle-income countries.The global nature of frailty in stroke necessitates global action. This World Stroke Organization Scientific Statement synthesizes the current evidence relating to the prevalence and effects of frailty across the stroke pathway. Furthermore, it includes expert consensus on priority areas from a global panel: standardization of frailty assessments for research, explicit measurements of frailty (in addition to disability) in large clinical trials, dedicated studies investigating the treatment-modifying effects of frailty in acute stroke and secondary prevention, research investigating the impact of frailty on the different aspects of recovery and rehabilitation after stroke, and understanding the mechanisms underpinning the relationship between frailty and stroke for potential therapeutic exploitation.This scientific statement has been reviewed and approved by the World Stroke Organization Executive.

Indexed as

FrailtyStrokeBiomedical ResearchGlobal HealthHumansStroke RehabilitationAcute stroke therapyfrailtyhemorrhageischemic strokerehabilitationreperfusionrisk factorsstrokestroke prevalencetreatment

Identifiers

PMID40390672
PMCPMC12446689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.